Clinical Trials Logo

Clinical Trial Summary

Aim 1: Assess directional signal of effect of fortified salt with folic acid and iodine on blood serum folate levels. It will be accomplished by feasibility pre-test/post-test clinical study by estimating mean and variability of serum blood folate levels effects of folic acid fortified salt. Hypothesis: Fortified salt with folic acid and iodine will increase serum blood folate levels from baseline by month 1. Aim 2: Assess feasibility and acceptability of salt fortified with folic acid and iodine. Feasibility will be measured by 1) subjects' refusal rate of consent by 30 subjects during 6-month enrollment period; 2) method of determining salt consumption (weighting the saltshaker pre and post); 3) completion rates of study protocols from baseline to follow up. Hypothesis 1a: Completion of all blood draw visits will be 90-100%. Acceptability will be measured by 1) completion rate of daily salt logs; 2) consumption of salt by weighting saltshakers; 3) attitude towards taste and color difference. Hypothesis 1b: Completion rate (90-100%) of daily salt logs will range from 90-100% of participants and 2) consumption of salt will range from 90-100% of participants. Dietary surveys will be employed to document dietary habits and estimated daily FA intake in the sample population. Feasibility and acceptability of dietary surveys will be measured by willingness to answer survey questions. Hypothesis 1c: Completion rate of dietary surveys will range 90-100%.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05935631
Study type Interventional
Source University of Alabama at Birmingham
Contact
Status Completed
Phase N/A
Start date January 24, 2023
Completion date June 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT05883761 - Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment
Terminated NCT04140669 - Automated Myocardial Performance Index Using Samsung HERA W10
Completed NCT01244399 - Influence of "Espresso" on Adsorption of Myo-inositol
Recruiting NCT03856034 - Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele N/A
Recruiting NCT04362592 - In-Utero Endoscopic Correction of Spina Bifida N/A
Recruiting NCT05672849 - Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases N/A
Active, not recruiting NCT03936322 - Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study N/A
Completed NCT01743196 - Folate Metabolism in Normal Weight and Obese Women of Child-bearing Age N/A
Active, not recruiting NCT03090633 - Fetoscopic Repair of Isolated Fetal Spina Bifida N/A
Completed NCT01392989 - Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders Phase 2
Completed NCT06174883 - Salt-FA to Increase Folate Levels
Recruiting NCT03315637 - Fetal Endoscopic Surgery for Spina Bifida N/A
Completed NCT00394862 - Efficacy of Weekly Versus Daily Folic Acid Supplementation N/A
Completed NCT04135274 - Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?
Completed NCT06135883 - Assessing Folic Acid in High-Risk Pregnancy for Neural Tube Defects
Active, not recruiting NCT04760509 - Short- Term Follow up Of Neonates Born With Neural Tube Defect
Active, not recruiting NCT03794011 - Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study Phase 1
Recruiting NCT04523233 - Metals/Vitamins Levels in NTD
Recruiting NCT01253746 - Genetics of Neural Tube Defects N/A
Completed NCT00468481 - Efficacy and Safety Study for an Oral Contraceptive Containing Folate Phase 3